BPA for balversa and carvykti

Active Awarded Last action

Contract number
36E79724A0034
Awardee
Awarding agency
Task orders
1 $20,500 obligated

Award facts

Opportunity
  • VA797P12Q0002 Solicitation number
Combined order value
$20,500 Current and potential, with all options
Last date to order 70% complete
IDV ceiling <1% used
$15,000,000.00
Award type
Single award
Who can order
Only the awarding agency
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Acquisition Center awarded a Blanket Purchase Agreement to Janssen Biotech Inc. on September 20, 2024, with a ceiling of $15 million for BALVERSA and CARVYKTI through September 19, 2027.

The BPA is established against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a $6.888 billion multiple-award schedule. Janssen Biotech supplies specialty oncology medications and biologic pharmaceuticals to the Veterans Health Administration under firm fixed-price terms. Performance occurs at facilities in Carrollton, Texas and Horsham, Pennsylvania, with delivery orders issued by regional Veterans Integrated Service Networks.

Recent BPA-call activity includes a $20,500.10 order from Veterans Integrated Service Network 5 on July 31, 2026, for BALVERSA 4 MG with completion by August 3, 2026. Order values across the BPA typically range from approximately $13,600 to $351,988, with nearly all delivery orders carrying thirty-day completion windows. VISN 5 leads by order count with 36 awards totaling $594 thousand, followed by VISN 20 with 11 orders totaling $530 thousand.

Task orders

Task order Ordering agency Obligated Awarded
Balversa 4 MG 36C24526N0789 Veterans Integrated Service Network 5 (VHA) $20,500

Transactions

Action Obligated Date
Exercise an Option P00004 · Exercise option year 2 - BPA 36E79724A0034 $0
Supplemental Agreement for work within scope P00003 · 2026 public law pricing updates. $0
Exercise an Option P00002 · This modification is issued to exercise option year 1 on BPA 36E79724A0034. $0
Supplemental Agreement for work within scope P00001 · 2025 public law pricing updates. $0
Original award $0

Quick answers

Who was awarded contract 36E79724A0034?

36E79724A0034 was awarded to Janssen Biotech Inc. by National Acquisition Center (Headquarters) on September 20, 2024.

How much is contract 36E79724A0034 worth?

Orders under 36E79724A0034 have obligated $20,500. 36E79724A0034's own ceiling is $15,000,000.

How many orders have been placed under contract 36E79724A0034?

1 order has been placed under 36E79724A0034, the latest on July 31, 2026.

Who can order from contract 36E79724A0034?

36E79724A0034 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.

Is contract 36E79724A0034 under another contract?

Yes. 36E79724A0034 is a blanket purchase agreement under 36F79724D0176, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36E79724A0034 competed?

The extent of competition for 36E79724A0034 was full and open competition. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV